Cargando…
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to evade neutralizing antibodies have emerged. Thus, earlier interest in defining the correlates of protection from infection, m...
Autores principales: | Bertoletti, Antonio, Le Bert, Nina, Tan, Anthony T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385766/ https://www.ncbi.nlm.nih.gov/pubmed/36049482 http://dx.doi.org/10.1016/j.immuni.2022.08.008 |
Ejemplares similares
-
SARS-CoV-2-specific T cells in infection and vaccination
por: Bertoletti, Antonio, et al.
Publicado: (2021) -
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
por: Bertoletti, Antonio, et al.
Publicado: (2021) -
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization
por: Bertoletti, Antonio, et al.
Publicado: (2022) -
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8(+) and CD4(+) T cells of broad specificity
por: Lim, Joey Ming Er, et al.
Publicado: (2022) -
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
por: Lim, Joey Ming Er, et al.
Publicado: (2022)